Li, X., Qi, H., Qing, G., Song, Z., Xie, L., Cao, F., . . . Fan, W. (2018). Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non‐small‐cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors. Thorac Cancer.
Chicago-stil citatLi, Xin, Han Qi, Gou Qing, Ze Song, Lin Xie, Fei Cao, Xiaoming Chen, och Weijun Fan. "Microwave Ablation With Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in Non‐small‐cell Lung Cancers With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors." Thorac Cancer 2018.
MLA-referensLi, Xin, et al. "Microwave Ablation With Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in Non‐small‐cell Lung Cancers With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors." Thorac Cancer 2018.